Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
are reviewed on a rolling basis. We will give preference to applications received by 30 March 2026, but will continue reviewing until the position is filled. For more information about the DPZ, please visit http
-
its employees in reconciling work and family life and regularly undergoes the audit berufundfamilie® . Further information at: http://www.ifw-dresden.de . The Institute for Materials Chemistry, Group
-
its employees in reconciling work and family life and regularly undergoes the audit berufundfamilie® . Further information at: http://www.ifw-dresden.de . The Institute for Emerging Electronic
-
consideration in cases of essentially equal qualification (§ 2 SGB IX). Contact and Application More information on the working group can be found here: https://www.leibniz-lsb.de/en/research/research-sections
-
here: https://www.leibniz-lsb.de/en/research/research-sections/section-iii . Please send your application, including a comprehensive CV and transcripts as well as names of three potential references, as
-
the application and selection process, please refer to the privacy policy on our homepage at https://www.senckenberg.de/en/imprint/ Please visit our website at www.senckenberg.de for further information about the
-
processes the personal data of its applicants in accordance with European and German legal regulations. Further information on data protection and the processing of personal data can be found at: https
-
part of the application and selection process, please refer to the privacy policy on our homepage at https://www.senckenberg.de/en/imprint/ Please visit our website at www.senckenberg.de for further
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu ) – is a biomedical research center focusing on translational immunology in the fields of cancer
-
, stating the reference number 04-2026 until 06 March 2026 to (see button e-mail application below). https://jobs.zalf.de/jobposting/ab9685e2d92d73417710c560540da8e7fc8bece70 If you have any questions, please